资讯

Zacks Small Cap Research on MSN1 小时
ENSC Start Phase 3 Trial on Abuse-Resistant Pain Reliever
ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing novel opioids that provide the needed pain relief, while greatly limiting the ...